Clinical Trials in Herning, Central Jutland
14 recruiting
Showing 1–14 of 14 trials
Recruiting
Phase 3
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
Non-small Cell Lung Cancer (NSCLC)
Merck Sharp & Dohme LLC614 enrolled218 locationsNCT06170788
Recruiting
Phase 3
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
Diffuse Large B Cell Lymphoma
Merck Sharp & Dohme LLC1,046 enrolled253 locationsNCT06717347
Recruiting
Phase 3
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma
Follicular Lymphoma ( FL)
Genmab1,095 enrolled266 locationsNCT06191744
Recruiting
Not Applicable
RESPONSE: Colorectal Cancer Survivors' Follow-up Care - Now Digital and Need-based
Colorectal, CancerSurvivorshipQuality of Life
University of Aarhus400 enrolled9 locationsNCT06614647
Recruiting
GUIDE.MRD-01-CRC: Clinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Colorectal Cancer
Liver Metastasis Colon CancerColorectal Cancer Stage III
Claus Lindbjerg Andersen590 enrolled15 locationsNCT06111105
Recruiting
Phase 3
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
HER2 MutationAdvanced Non-Small Cell Lung Cancer
Bayer444 enrolled283 locationsNCT06452277
Recruiting
Phase 3
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
AbbVie420 enrolled61 locationsNCT06810505
Recruiting
Phase 3
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Episodic Migraine
AbbVie450 enrolled98 locationsNCT05711394
Recruiting
Not Applicable
Biannual Screening for HCC Offered to Patients With Cirrhosis. Introducing Surveillance for Hepatocellular Carcinoma (HCC) in the Central Denmark Region Using Ultrasound and Alpha-Fetoprotein to Reduce HCC-Related Mortality in Patients With Compensated Non-Viral Cirrhosis
CirrhosisHepatocellular Carcinoma (HCC)
University of Aarhus617 enrolled6 locationsNCT07469319
Recruiting
DANISH.MRD: Danish Assessment of Minimal Residual Disease by Liquid Biopsies
Colorectal, CancerColorectal NeoplasmsColorectal Adenocarcinoma+3 more
University of Aarhus1,600 enrolled10 locationsNCT06076811
Recruiting
Not Applicable
Perfusion Estimation For Optimal Treatment Strategy in Chronic Coronary Syndrome
Myocardial IschemiaCoronary Artery DiseaseChronic Coronary Syndrome+1 more
Gødstrup Hospital570 enrolled1 locationNCT05865600
Recruiting
Not Applicable
The BEGIN Study Bifidobacterium Infantis to Newborns: Effects of Modulating the Gut Microbial Composition on Growth, Immune Function and Inflammatory Conditions - a Randomized Placebo-controlled Double-blinded Intervention Trial
HealthyHealthy Nutrition
University of Aarhus1,000 enrolled2 locationsNCT06452199
Recruiting
Phase 4
Can Patients With Atrial Fibrillation Safely Discontinue Anticoagulant Therapy After Cardiac Surgery? (ATLAAC)
Atrial FibrillationAnticoagulant Adverse ReactionLeft Atrial Appendage Absent
Odense University Hospital1,220 enrolled6 locationsNCT06401616
Recruiting
Not Applicable
Longitudinal Study of Local Ablative Therapy in Oligometastatic Disease
SurgeryOligometastatic DiseaseRadiotherapy+3 more
Gitte Fredberg Persson MD PhD1,200 enrolled11 locationsNCT06356779